| 0.948 | 0 | 0.948 | Hematopoietic | | |
| 0.756 | 0.001 | 0.756 | Guanylate cyclase 1 stimulant | | |
| 0.737 | 0.005 | 0.737 | Antioxidant | | |
| 0.72 | 0.027 | 0.72 | Antiinflammatory | | |
| 0.654 | 0.001 | 0.654 | Guanylate cyclase stimulant | | |
| 0.427 | 0.065 | 0.427 | Antibacterial | | |
| 0.334 | 0.036 | 0.334 | Antimitotic | | |
| 0.204 | 0.004 | 0.204 | Anabolic | | |
| 0.342 | 0.144 | 0.342 | Apoptosis agonist | | |
| 0.234 | 0.056 | 0.234 | Nitric oxide antagonist | | |
| 0.157 | 0.045 | 0.157 | DNA polymerase I inhibitor | | |
| 0.085 | 0.018 | 0.085 | Nitric oxide donor | | |
| 0.035 | 0.015 | 0.035 | Purinergic P2X agonist | | |
| 0.167 | 0.154 | 0.167 | Peptidyltransferase inhibitor | | |
| 0.026 | 0.015 | 0.026 | Adenosine A1 receptor agonist | | |
| 0.027 | 0.018 | 0.027 | Toll-Like receptor 4 agonist | | |